Authors:
KASHUBA ADM
NAFZIGER AN
KEARNS GL
LEEDER JS
SHIREY CS
GOTSCHALL R
GAEDIGK A
BERTINO JS
Citation: Adm. Kashuba et al., QUANTIFICATION OF INTRAINDIVIDUAL VARIABILITY AND THE INFLUENCE OF MENSTRUAL-CYCLE PHASE ON CYP2D6 ACTIVITY AS MEASURED BY DEXTROMETHORPHANPHENOTYPING, Pharmacogenetics, 8(5), 1998, pp. 403-410
Authors:
KASHUBA ADM
NAFZIGER AN
KEARNS GL
LEEDER JS
GOTSCHALL R
ROCCI ML
KULAWY RW
BECK DJ
BERTINO JS
Citation: Adm. Kashuba et al., EFFECT OF FLUVOXAMINE THERAPY ON THE ACTIVITIES OF CYP1A2, CYP2D6, AND CYP3A AS DETERMINED BY PHENOTYPING, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 257-268
Authors:
KASHUBA ADM
BERTINO JS
KEARNS GL
LEEDER JS
JAMES AW
GOTSCHALL R
NAFZIGER AN
Citation: Adm. Kashuba et al., QUANTITATION OF 3-MONTH INTRAINDIVIDUAL VARIABILITY AND INFLUENCE OF SEX AND MENSTRUAL-CYCLE PHASE ON CYP1A2, N-ACETYLTRANSFERASE-2, AND XANTHINE-OXIDASE ACTIVITY DETERMINED WITH CAFFEINE PHENOTYPING, Clinical pharmacology and therapeutics, 63(5), 1998, pp. 540-551
Authors:
NAFZIGER AN
KASHUBA ADM
JAMES A
KEARNS GL
LEEDER JS
GOTSCHALL R
BERTINO JS
Citation: An. Nafziger et al., THE INFLUENCE OF SEX AND MENSTRUAL-CYCLE (MC) ON CYP1A2, NAT2 AND XANTHINE-OXIDASE (XO) ACTIVITY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 36-36
Authors:
BERTINO JS
KASHUBA ADM
SHIREY C
KEARNS GL
LEEDER JS
GOTSCHALL R
NAFZIGER AN
Citation: Js. Bertino et al., LONG-TERM INTRAINDIVIDUAL VARIABILITY (VAR) AND THE INFLUENCE OF SEX ON CYP2D6 ACTIVITY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 63-63
Authors:
KASHUBA ADM
NAFZIGER AN
KEARNS GL
LEEDER JS
GOTSCHALL R
ROCCI ML
KULAWY RW
BECK DJ
BERTINO JS
Citation: Adm. Kashuba et al., EFFECT OF FLUVOXAMINE THERAPY ON THE ACTIVITIES OF CYP1A2, CYP2D6, AND CYP3A, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 66-66
Authors:
GOTSCHALL R
LEEDER JS
FARRAR H
MCCUBBIN M
JOHNSON K
KEARNS GL
Citation: R. Gotschall et al., CAFFEINE PLASMA-CLEARANCE IN CYSTIC-FIBROSIS (CF) DOES NOT CORRELATE WITH CYP1A2 ACTIVITY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 79-79